Takotsubo Common Pathways and SNRI Medications

We read with great interest the perspectives of Tavazzi et al. [(1)][1] regarding Takotsubo syndrome (TTS), neurogenic stress cardiomyopathy, and the prevailing hypothesis of common catecholamine-mediated pathways. The Division of Pharmacovigilance at the U.S Food and Drug Administration reviewed